Table 2 indicates that there was significant dyslipidemia in NAFLD patients when compared to the healthy, age-matched control group. Table 2 reveals that the examined groups differed significantly in terms of BMI, ALT, and AST. The gene discussed is GPT; the disease is metabolic syndrome.